COYA vs OMC · rev $7.9M vs rev $17.27B
Coya Therapeutics, Inc. Common Stock (COYA) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
COYA currently screens at market cap $118.0M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the COYA and OMC stock pages for the full models.
Not investment advice.